The effects of the ischemic protectants taurine (107357) (TA) and ketamine (6740881) (KE) on bovine retinal membrane lipid peroxidation were investigated. Bovine eyes and retinas were subjected to ischemia. Retinal cells or rod outer segments were isolated. The tissues were exposed to the lipid peroxidation inducers cadmium-chloride (10108642) (CC) and L-ascorbic-acid (50817) (AA) in the presence of TA (0 to 5 millimolar (mM)), KE (0 to 10mM), kynurenic acid (492273) (1mM), dextromethorphan (125713) (1mM), or trifluoperazine (117895) (TFP). Lipid peroxidation was measured by the thiobarbiturate assay. Results showed that 30 minutes (min) exposure to CC or AA increased the basal thiobarbituric-acid reactive substance value of lipid peroxidation to 0.637 and 0.457OD/mg protein, respectively, from a basal value of 0.273OD/mg protein. TFP caused a dose dependent reduction in lipid peroxidation. No significant difference was seen with low (0.1 or 1.0mM) KE, although 9mM or 10mM KE significantly reduced it. TA failed to alter lipid peroxidation of P2 membranes. Similar effects were found with isolated retinal cells. With intact eyes, KE reduced lipid peroxidation to 55% control values, but TFP was less effective, and TA failed to prevent lipid peroxidation of the retinal membrane. KE prevented glutathione depletion during in- vitro ischemia, but TA was without effect. The authors conclude that different mechanisms seem to underlie the ischemic protective properties of TA and KE as ischemic protectants, and that lipid peroxidation may not be critical to the antihypoxic property of TA.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.